SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
Clinical trial NCT06822010 · RECRUITING
Trial details
- NCT number
- NCT06822010
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-06
- Primary completion
- 2028-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.